摘要
目的:评价托烷司琼与格拉司琼联合甲氧氯普胺预防化疗所致恶心、呕吐的治疗效果及成本-效益比。方法:收集2012年1月至2012年11月经病理学和细胞学证实的恶性肿瘤(食管癌、鼻咽癌)80例,随机分为A组40例、B组40例,分别应用托烷司琼及格拉司琼联合甲氧鲁普胺预防化疗所致恶心、呕吐,观察止吐效果并进行成本-效益分析。结果:A、B两组止吐有效率分别为92.5%和87.5%(P>0.05);成本/效益比分别为2.06和0.70。结论:托烷司琼与格拉司琼联合甲氧氯普胺预防化疗所致恶心、呕吐的疗效相似,但后者成本-效益比好。
Objective:To evaluate the effectiveness and cost of tropisetron plus metoclopramide and granisetron plus metoclopramide to prevent chemotherapy-induced nausea and vomiting. Methods : From January 2012 to November 2012,80 patients with nasopharynge al carcinoma and esophageal carcinoma were randomly divided into two groups:A and B,which are proved by pathology and cytology. The patients in the A or B group respectively receive tropisetron or granisetron and metoclopramide to prevent chemotherapy-induced nausea and vomiting. The result of vomit-stopping was observed and the effectiveness and cost were analyzed. Results : The effective rate of group A and B was 92.5 % and 87.5% ( P 〉 0. 05 ) ; proportionality of effectiveness and cost was 2. 06 and 0. 70. Conclusion : The effects of tropisetron joint metoclopramide and granisetron joint metoclopramide used to prevent chemotherapy-induced nausea and vomi ting resembled;and the cost of receiving granisetron plus metoclopramide can be reduced.
出处
《川北医学院学报》
CAS
2014年第2期177-180,共4页
Journal of North Sichuan Medical College
基金
四川省卫生厅科研项目(100149)
关键词
托烷司琼
格拉司琼
甲氧氯普胺
成本-效益分析
恶心
呕吐
Tropisetron
Granisetron
Metoclopramide
Analysis of effectiveness and cost
Nausea
Vomiting